Detalhe da pesquisa
1.
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
N Engl J Med
; 390(1): 20-31, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916620
2.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
N Engl J Med
; 389(26): 2436-2445, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921461
3.
Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
Lancet
; 403(10433): 1279-1289, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492578
4.
Detection of PatIent-Level distances from single cell genomics and pathomics data with Optimal Transport (PILOT).
Mol Syst Biol
; 20(2): 57-74, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177382
5.
Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?
Kidney Int
; 105(4): 659-661, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519229
6.
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.
Kidney Int
; 105(1): 189-199, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914086
7.
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.
Kidney Int
; 105(6): 1306-1315, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552841
8.
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
Lancet
; 402(10405): 859-870, 2023 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591292
9.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Lancet
; 401(10388): 1584-1594, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015244
10.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931634
11.
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
Nephrol Dial Transplant
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573822
12.
Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA Vasculitis.
J Immunol
; 209(6): 1048-1058, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985788
13.
Conditional power and information fraction calculations at an interim analysis for random coefficient models.
Pharm Stat
; 23(2): 276-283, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919258
14.
IgA nephropathy: the lectin pathway and implications for targeted therapy.
Kidney Int
; 104(2): 254-264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263354
15.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Kidney Int
; 103(2): 391-402, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270561
16.
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management.
Kidney Int
; 103(2): 264-281, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481180
17.
Segregation analysis identifies specific alpha-defensin (DEFA1A3) SNP-CNV haplotypes in predisposition to IgA nephropathy.
Ann Hum Genet
; 87(1-2): 1-8, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214424
18.
An update on corticosteroid treatment for IgA nephropathy.
Curr Opin Nephrol Hypertens
; 32(3): 263-270, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866805
19.
Clinical application of microRNAs in glomerular diseases.
Nephrol Dial Transplant
; 38(6): 1375-1384, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906877
20.
The role of complement in glomerulonephritis-are novel therapies ready for prime time?
Nephrol Dial Transplant
; 38(8): 1789-1797, 2023 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307926